Towards Healthcare Research & Consulting
US AI in Life Science Market
Updated Date: 20 July 2026   |   Report Code: 6917
[email protected] +1 804-441-9344
Download Sample Order Now

US AI in Life Science Market Growth and Trends 2035

According to Shivani Zoting, who specializes in biotechnology, pharmaceuticals, digital health, and healthcare intelligence, with 5+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the U.S. electronic health records market. The U.S. AI in life science market size was estimated at USD 0.95 billion in 2025 and is predicted to increase from USD 1.14 billion in 2026 to approximately USD 5.91 billion by 2035, expanding at a CAGR of 20.05% from 2026 to 2035. Her analysis highlights that the market is growing due to the rising need for fast data analysis, the rise in healthcare data due to a large patient pool, and clinical trials. The research also examines the competitive strategies of key industry participants, including Pfizer, Sanofi, Novartis & Eli Lilly, AstraZeneca, and Insilico Medicine, that are supporting the growth of the market.

Last Updated : 20 July 2026 Category: Life Sciences Insight Code: 6917 Format: PDF / PPT / Excel

Content

Chapter 1: Introduction

  • Market Definition & Taxonomy
  • Research Objectives
  • Market Scope & Assumptions
  • Study Timeline (Historical, Base Year, Forecast Period)
  • Key Stakeholders Covered

Chapter 2: Research Methodology

  • Research Framework Overview
  • Market Size Estimation Methodology
    • Bottom-Up Approach
    • Top-Down Approach
  • Forecasting Model
    • Dependent Variables
    • Independent Variables
    • Key Assumptions & Weightages
  • Primary Research Insights
  • Secondary Data Sources
  • Data Validation & Triangulation

Chapter 3: Executive Summary

  • Global & Regional Overview (Value, CAGR)
  • Epidemiology Snapshot
  • Segmental Overview
  • Competition Key Snippets
  • Strategic Takeaways

Chapter 4: Market Catalysts, Constraints & Growth Levers

  • Market Dynamics
  • Market Drivers/Catalysts
    • Driver 1
    • Driver 2
  • Market Restraints
    • Restraint 1
    • Restraint 2
  • Market Opportunities
    • Opportunity 1
    • Opportunity 2
  • Market Trends
    • Trend 1
    • Trend 2
  • Impact Assessment of Drivers, Restraints, Opportunities & Trends (High, Mid, & Low)

Chapter 5: Value Added Intelligence

  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers: Low/Moderate/High
    • Bargaining Power of Buyers: Low/Moderate/High
    • Threat of New Entrants: Low/Moderate/High
    • Threat of Substitute: Low/Moderate/High
    • Competitive Rivalry: Low/Moderate/High
  • PESTEL Analysis
  • Ecosystem Analysis
  • Mapping of Key Players
  • Value Chain Analysis
  • Margin Analysis Across Value Chain
  • Macro & Micro Factors Impacting Market
  • Market Potential Evaluation, By Region
  • Epidemiology & Patient Pool Analysis
    • Disease Incidence & Prevalence
    • Target Patient Pool
      • Diagnosed Population
      • Service-Seeking Population
    • Patient Flow & Utilization Analysis
      • Patient Footfall
      • Admission Rates
      • Procedure Volume
    • Healthcare Infrastructure Analysis
      • Number of Facilities
        • Hospitals
        • Clinics
        • Diagnostic Centers
        • ASCs
      • Bed Capacity
        • Total Beds
        • ICU Beds
      • Facility Distribution
    • Operational Metrics Analysis
      • Bed Occupancy Rate (%)
      • Average Length of Stay (ALOS)
    • Service Pricing & Revenue Model
      • Pricing Analysis
        • Cost per Procedure
        • Cost per Consultation
        • Cost per Diagnostic Test
      • Revenue Streams
        • Inpatient Services
        • Outpatient Services
        • Ancillary Services
      • Workforce & Staffing Analysis
        • Healthcare Workforce
          • Physicians
          • Nurses
          • Technicians
        • Staff-to-Patient Ratios
        • Skill Gap Analysis
        • Labor Cost Structure
      • Scenario Analysis (Base / Optimistic / Pessimistic)
      • Risk Assessment & Sensitivity Analysis
      • Opportunity Analysis, By Region
      • Regulatory Analysis
      • Sustainability & ESG Insights
      • Business Models
      • Investment & Funding Landscape
      • Key Conferences and Events

Chapter 7: Segmental & Regional Analysis

  • U.S. AI in Life Science Market Analysis, By Component
    • Market Size, Forecast & CAGR, By Component, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • U.S. AI in Life Science Market Analysis, By Technology
    • Market Size, Forecast & CAGR, By Component, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • U.S. AI in Life Science Market Analysis, By Application
    • Market Size, Forecast & CAGR, By Component, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • U.S. AI in Life Science Market Analysis, By Deployment Mode
    • Market Size, Forecast & CAGR, By Component, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • U.S. AI in Life Science Market Analysis, By Enterprise Size
    • Market Size, Forecast & CAGR, By Component, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • U.S. AI in Life Science Market Analysis, By Delivery Mode
    • Market Size, Forecast & CAGR, By Component, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis

Chapter 6: Competitive Insights

  • Competitive Analysis
    • Company Evaluation Matrix
      • Major Players
      • Mid-Sized Companies
      • Emerging Players/Start-Ups
    • Global Market Share Analysis, By Region, 2025 (%)
    • Key Player Positioning
    • Competitive Benchmarking
      • By Component
      • By Technology
      • By Application
      • By Deployment Mode
      • By Enterprise Size
      • By Delivery Mode
    • Strategies of Key Players
    • Insight From the Horse’s Mouth
  • Company Profiles
    • Pfizer
      • Company Name
      • Company Headquarters
      • Management Overview
        • Key C-Suite Executives
          • CEO
          • MD
          • Others
        • Employee Count
        • Business Strategy
          • Key Investments Made
          • Future Plans
          • R&D & Innovation Capabilities
          • Recent Developments
            • New Product Launch
            • Merger & Acquisitions
            • Partnerships & Collaborations
            • Market Expansion
            • Others
          • Service Portfolio
          • Facility Network
            • Number of Facilities
            • Bed Capacity
            • Facility Distribution
            • Expansion Pipeline
          • Key Financials (2022-2025)
            • Revenue By Segment
            • Revenue By Service
            • Revenue By Geography
            • Financial Matrix (Gross Profit Margins, Net Margins, etc.)
          • Key Clients
            • Client Company Name
            • Key Contact Person
            • Contact Details
          • Regulatory & Certification Expertise
          • SWOT Analysis
    • Sanofi
    • Novartis & Eli Lilly
    • AstraZeneca
    • Insilico Medicine

FAQ's

Answer : The U.S. AI in the life science market in 2026 is valued at USD 1.14 billion and is projected to climb to USD 5.91 billion by 2035, with a CAGR of 20.05% over the forecast period.

Answer : National Institutes of Health, FDA, WHO, CDC.
Any Questions

Meet the Team

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and strategy.

Learn more about Shivani Zoting

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar